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Should organ donors be paid?The number of patients requiring an organ transplant in
the UK has increased by 9% during 2005e2006.1 In the
2005e2006 activity summary report produced by the UK
Transplant organisation, it was stated that 8315 patients
were registered on a solid organ transplant list. Fig. 1 shows
the number of patients on the active waiting list for a trans-
plant at 31 March 2005 and 2006.
The demand for organs means that the number of organ
donors has to increase. The current shortage of organs has
led to some cases whereby patients have contracted with
organ brokers to purchase organs such as kidneys from living
donors. This is illegal in the majority of countries; therefore
people may travel to the donor’s home country for the
transplantation.3,4 A national audit conducted within the UK
identified 23 patients who had committed such acts of renal
transplantation against medical advice. The outcome of
these transplants was that 35% of these patients died shortly
after their return to the UK and a further 21% lost their kid-
neys. In the short term only 44% of these patients had suc-
cessful outcomes.5 This poses a matter of the ethics of
post-transplantation care in the UK for someone who has
had a transplant abroad against medical advice. A BBC re-
port found that in China, organs from executed prisoners
were in fact being sold to rich foreigners.6 In addition a web-
site www.matchingdonors.com exists. The website emerged
in 2004, and functions by patients registering their details
and awaiting positive responses from potential donors.
This website claims to have more than 2100 registered po-
tential donors and to have brokered 12 transplantations.7
These are just three examples of the measures taken by
some people in society to overcome the lengthy waiting
times associated with organ transplants. In 1994, the World
Medical Association banned incentive schemes because of
reports of ‘‘transplant tourism’’, and the presence of an un-
regulated organ market which was thriving in developing
countries. Both UK and US legislation prohibits the offering
of financial incentives (the 1989 Human Organ Transplant
Act and 1984 Uniform Anatomical Gift Act/National Organ
Transplant Act, respectively).8
Organ donation is the gift of an organ to help someone
who needs a transplant.9 In my mind this definition1743-9191/$ - see front matter ª 2007 Surgical Associates Ltd. Publish
doi:10.1016/j.ijsu.2007.05.005immediately gives rise to the debate of payment to organ
donors. Surely a gift is something that is given without
the expectation of return?National policies on organ donation
Let us consider the legal policies surrounding organ dona-
tion. In the UK, prior to the 1 September 2006, relatives of
the deceased could override the decision of the deceased
to donate their organs and tissue. Now, due to changes in
the Human Tissue Act 2004, this is not so and relatives do
not have the legal right to do so. It is the wishes of the
deceased that take priority. Spain, Belgium and Austria
operate an opt-out policy, sometimes referred to as ‘pre-
sumed consent’. Implementation of this policy does vary,
but in general, those individuals who object to donating
their organs should state this on a national register. Those
persons who do not register are automatically presumed to
be eligible donors, unless their relatives explicitly object.10
In Spain, a soft opt-out system is operated, whereby the
relatives views’ are considered, and they can refuse dona-
tion even if the deceased wanted to donate their organs. In
Belgium the presumed consent legislation was passed in
1986.10 One study showed that two similar transplant cen-
tres in Belgium (one in Leuven and one in Antwerp), showed
staggering differences in the donation rate. The centre in
Leuven adopted the presumed consent policy in line with
the policy, and in three years, its donation rate increased
from 15 to 40 donors per million. However, Antwerp did
not change its policy and maintained its previous levels of
organ donation.10,11 In Austria, presumed consent became
law in 1982. By 1990, the rates of donation had quadrupled,
to the extent where the number of patients awaiting kid-
neys nearly equalled the number of kidney transplants
performed.10,12 It seems clear that the number of organs
available for donation increases when policies such as
presumed consent are put into place. However, the ever
increasing demand for organs calls for other measures,
the most apparent being organ donation from living donors.
I am of the opinion that a system of presumed consented by Elsevier Ltd. All rights reserved.
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182 Editorialwould be beneficial. I feel that this may help to bring the
general publics’ consensus to that of all cadaveric dona-
tions being the ‘norm’, whilst allowing those who object
to cadaveric donation explicitly stating so on a national reg-
ister. If this scheme was put in place, perhaps we would not
need to offer incentives for live organ donation, as the
demand may be met through altruistic donation from
cadaveric and living donors.
Organ donation from living donors
In the USA, payment for donation of bodily material such as
hair, blood, sperm, eggs and uterus-hire for surrogate
pregnancies is legal, so why shouldn’t people receive
payment for donating a kidney or lobes of their lungs?
The first point to consider is that families of deceased
donors often consider organ donation as a way of giving
meaning to the death of their loved ones, or, a way in which
the departed ‘‘lives on’’ in others. Living donors, be it spouses
or siblings, feel the personal reward of seeing their family
member’s health restored.13 Both these examples are of vol-
untary donation, where people view their act to be charitable.
Lets now assess the benefits of legalising payment for
organs. It is argued that the key benefit would be to those
people from developing countries; exploitation of such
people would be limited, providing such a law clearly
stated that donors had to be legal residents of the
recipient’s country.4 In 2002 the price of a woman’s kidney
in Bombay was said to be $1000, in the Philippines a male
kidney was around $2000, and in Latin America in 2002,
a kidney could be sold for over $10,000.13 One can only
imagine what small value is given to the donor themselves,
in comparison to the brokers. In a cross-sectional survey
conducted in February 2001 among 305 individuals who
had sold a kidney in Chennai, India, the authors found
that the average amount received by the donor for selling
a kidney was $1070. The amount promised for selling a kid-
ney averaged $1410 (range, $450e$6280), while the
amount actually received averaged $1070 (range, $450e
$2660). Both middlemen and clinics promised on average
about one-third more than they actually paid.14
In another context, incentives or benefits for family
members who consent to the donation of their departedloved ones has been considered.15 The possibility of partial
reimbursement of funeral expenses to the deceased
donor’s family has been discussed. A proposed programme
in Pennsylvania, supported by The American Society of
Transplant Surgeons, involved providing a small reimburse-
ment sum of $300. This small value was meant to stress the
purpose of the programme, which was to convey apprecia-
tion for the donation, as opposed to providing payment
for it.13 This programme was in fact halted due to
concerns that the provision of funeral benefits violated fed-
eral law. A study in Pennsylvania was conducted shortly af-
ter this proposed programme, to find out what people
thought about issues relating to such incentives and bene-
fits. Out of the five types of benefits they were asked about
(funeral benefits, charitable contributions, travel/lodging
expenses, direct payment and medical expenses), it was
found that direct payment received the lowest level of
support.15
An ethical reappraisal on financial incentives for cadaver
organ donation summarises the main reasons against
payment for organs. The panel included ethicists, organ
procurement organisation executives, physicians and sur-
geons. All were opposed to the exchange of money for
cadaver organ donors, on the basis that monetary involve-
ment dishonoured the spirit of altruism in organ donation
and commercialised the value of human life.15
Taking this debate one step further, the topic of
payment for blood donation is another important issue to
consider. In New Zealand, changes in the blood transfusion
service meant that essentially, it was required to be profit
driven. A national trust was initiated in order to sustain the
gift relationship and to ensure that there would be no
profiteering in blood. However, costs associated with
collecting, processing, and distributing blood products can
be passed on to providers, who are later reimbursed.16
Howden-Chapman et al. investigated the attitudes of blood
donors to this change in service. The outcome was that over
50% of the 345 donors questioned, were in actual fact,
opposed to profits being made from blood. An astounding
41% were of the standing that they would no longer give
blood if profits were made from selling blood products.17
The investigations discussed have focussed on certain
groups of people, however, the overall opinions derived
from these people, perhaps may reflect a broader view
within societye the donation of blood and organs, are a gift,
and furthermore human life should not be commercialised.
In conclusion, attempts to increase the number of organs
available for transplantation will continue as the challenge
of a demand and supply mismatch grows. Perhaps appro-
priate guidance and consequent legislation to manage the
sale of organs through an official regulatory body should be
next on the agenda for governments and transplant orga-
nisations worldwide. Or do we, as a society accept organ
donation to be altruistic in nature, and, consequently
forbid any financial involvement in this matter?References
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